BioCorRx (BICX) Long-Term Debt Issuances (2011 - 2026)
BioCorRx recorded quarterly Long-Term Debt Issuances of $85904.0 in Q1 2026, up 109.11% quarter-over-quarter from -$942700.0 in Q4 2025, and down 86.43% year-over-year from $633100.0 in Q1 2025.
BioCorRx's Long-Term Debt Issuances history runs 13 years deep, the most recent figure standing at $85904.0 for Q1 2026.
- In Q1 2026, Long-Term Debt Issuances fell 86.43% year-over-year to $85904.0; the TTM figure through Mar 2026 stood at -$547196.0 (down 140.1% YoY), while the FY2024 annual figure was $931502.0, up 55.25% from the prior year.
- Long-Term Debt Issuances came in at $85904.0 for Q1 2026 at BioCorRx, up from -$942700.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $675000.0 in Q4 2022 to a low of -$942700.0 in Q4 2025.
- A 5-year average of $176338.9 and a median of $200000.0 in 2024 frame the typical range for Long-Term Debt Issuances.
- On a YoY basis, Long-Term Debt Issuances climbed as much as 216.55% in 2025 and fell as far as 379.34% in 2025.
- BioCorRx's Long-Term Debt Issuances stood at $675000.0 in 2022, then tumbled by 40.74% to $400000.0 in 2023, then decreased by 15.63% to $337477.0 in 2024, then slumped by 379.34% to -$942700.0 in 2025, then jumped by 109.11% to $85904.0 in 2026.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $85904.0, -$942700.0, and $95000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 14.00 Mn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 1.26 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 250.00 Mn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 582.91 Mn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 135.48 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | - |
| 10 | BioCorRx | - | - | 189,355.00 | 85,904.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85,904.00 |
| Mar 31, 2026 | 85,904.00 |
| Dec 31, 2025 | 205,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 95,000.00 |
| Sep 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 214,600.00 |
| Jun 30, 2025 | 214,600.00 |
| Mar 31, 2025 | 633,100.00 |
| Mar 31, 2025 | 633,100.00 |
| Sep 30, 2024 | -35,396.00 |
| Sep 30, 2024 | -35,396.00 |
| Jun 30, 2024 | 35,396.00 |
| Jun 30, 2024 | 35,396.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 293,273.00 |
| Sep 30, 2023 | 293,273.00 |
| Jun 30, 2023 | -132,768.00 |
| Jun 30, 2023 | -132,768.00 |
| Mar 31, 2023 | 182,768.00 |
| Mar 31, 2023 | 182,768.00 |
| Dec 31, 2022 | -220,000.00 |
| Dec 31, 2022 | -220,000.00 |
| Sep 30, 2022 | 320,000.00 |
| Sep 30, 2022 | 320,000.00 |
| Dec 31, 2021 | -68,560.00 |
| Dec 31, 2021 | -68,560.00 |
| Dec 31, 2018 | 500,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Mar 31, 2018 | 250,000.00 |
| Mar 31, 2018 | 250,000.00 |
| Mar 31, 2017 | 1.66 Mn |
| Mar 31, 2017 | 1.66 Mn |
| Dec 31, 2016 | 450,000.00 |
| Dec 31, 2016 | 450,000.00 |
| Jun 30, 2016 | 2.19 Mn |
| Jun 30, 2016 | 2.19 Mn |
| Mar 31, 2016 | 74,448.00 |
| Mar 31, 2016 | 74,448.00 |
| Dec 31, 2015 | -219,500.00 |
| Dec 31, 2015 | -219,500.00 |
| Sep 30, 2015 | 325,000.00 |
| Sep 30, 2015 | 325,000.00 |
| Jun 30, 2015 | 25,000.00 |
| Jun 30, 2015 | 25,000.00 |
| Mar 31, 2015 | 50,000.00 |
| Mar 31, 2015 | 50,000.00 |
| Mar 31, 2014 | 76,750.00 |
| Mar 31, 2014 | 76,750.00 |
| Mar 31, 2013 | 200,000.00 |
| Mar 31, 2013 | 200,000.00 |
| Dec 31, 2012 | 75,000.00 |
| Dec 31, 2012 | 75,000.00 |
| Sep 30, 2012 | 648,675.00 |
| Sep 30, 2012 | 648,675.00 |
| Jun 30, 2012 | 116,025.00 |
| Jun 30, 2012 | 116,025.00 |
| Mar 31, 2012 | 45,300.00 |
| Mar 31, 2012 | 45,300.00 |
| Dec 31, 2011 | 1,939.00 |
| Dec 31, 2011 | 1,939.00 |
| Sep 30, 2011 | -20,938.00 |
| Sep 30, 2011 | -20,938.00 |
| Jun 30, 2011 | 45,532.00 |
| Jun 30, 2011 | 45,532.00 |
| Mar 31, 2011 | 101,455.00 |
| Mar 31, 2011 | 101,455.00 |